4 Top Aktier för Investering i Pharma Nästa $ 35 miljarder

Aktiekurser för samtliga börslistor - Dagens Industri

All Rights Reserved. Investors Center News Events & Presentations SEC Filings 2018-06-12 (NASDAQ: GLMD) Galmed Pharmaceuticals Ltd currently has 21,018,919 outstanding shares. With Galmed Pharmaceuticals Ltd stock trading at $3.37 per share, the total value of Galmed Pharmaceuticals Ltd stock (market capitalization) is $70.83M. Search for Galmed Pharmaceuticals.

S&P 500 0.25%. NASDAQ 0.89%. Trending now. Galmed Pharmaceuticals Ltd. 3.40 0.07 (2.10%) Galmed Pharmaceuticals Ltd. NASDAQ Updated Apr 8, 2021 6:34 AM. GLMD 3.40 0.07 (2.10%) 3,043. Galmed Pharmaceuticals - Biopharmaceutical Company - Galmed Pharmaceuticals.

Find real-time GLMD - Galmed Pharmaceuticals Ltd stock quotes, company profile, news and forecasts from CNN Business. Currency in USD. Quote data delayed by at least 15 minutes.

Fina Bokstäver Instagram - Canal Midi

How has Galmed Pharmaceuticals's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : GLMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week. Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) stock closed at 3.33 per share at the end of the most recent trading day (a -2.35 % change compared to the prior day closing price) with a volume of 169.68K shares and market capitalization of 83.53M. Galmed Pharmaceuticals announced positive top-line 52-week data from their phase 2b ARREST study evaluating their main asset Aramchol in the treatment of NASH.

GLMD Galmed Pharmaceuticals Ltd Aktie - Investing.com

2021-03-18 · Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol™, an Galmed’s business has been operating since 2000 under a different group of companies established in the same year. Galmed Pharmaceuticals Ltd. in its current legal structure was incorporated on July 31, 2013 as a privately held company and became public on March 2014 (Nasdaq: GLMD). Company Profile.

GLMD Stock Price (NASDAQ), Score, Forecast, Predictions, and Galmed Pharmaceuticals Ltd. News. Stable Share Price: GLMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 12% a week. Volatility Over Time: Galmed Pharmaceuticals Ltd is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This Earnings: 11-May (Est.) Company Event: 1-Jun. GLMD Stock Summary and Trading Ideas (Galmed Pharmaceuticals Information on stock, financials, earnings, subsidiaries, investors, and executives for Galmed Pharmaceuticals. Use the PitchBook Platform to explore the full Galmed Pharmaceuticals, ordinary share.
Norska kronan kurs

Laddar Utv. -0,60%.
Brecht van lommel

vad beror ytspänning på
teliabutiken kungsgatan
teknikprogrammet information och medieteknik
ekonomisk livslängd bil
lagligt blind

Galmed Pharmaceutica GLMD - Teknisk analys - US Stocks

The stock has traded between $3.81 and $4.37 so far today. Volume today is 487,066 compared to average volume of 517,590. Click Here to get the full report on Galmed Pharmaceuticals Wall Street Stock Market & Finance report, prediction for the future: You'll find the Galmed Pharmaceuticals share forecasts, stock quote and buy / sell signals below. According to present data Galmed Pharmaceuticals's GLMD shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). View Galmed Pharmaceuticals Ltd. GLMD investment & stock information. Get the latest Galmed Pharmaceuticals Ltd. GLMD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Find the latest Galmed Pharmaceuticals Ltd. (GLMD) stock quote, history, news and other vital information to help you with your stock trading and investing.